Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4633234
Max Phase: Preclinical
Molecular Formula: C28H27ClFN5O5S
Molecular Weight: 600.07
Molecule Type: Unknown
Associated Items:
ID: ALA4633234
Max Phase: Preclinical
Molecular Formula: C28H27ClFN5O5S
Molecular Weight: 600.07
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1c(N2CCN(CC(=O)Nc3nc4c(Cl)cccc4s3)C(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
Standard InChI: InChI=1S/C28H27ClFN5O5S/c1-14-11-34(9-8-33(14)13-21(36)31-28-32-22-18(29)4-3-5-20(22)41-28)24-19(30)10-16-23(26(24)40-2)35(15-6-7-15)12-17(25(16)37)27(38)39/h3-5,10,12,14-15H,6-9,11,13H2,1-2H3,(H,38,39)(H,31,32,36)
Standard InChI Key: GVKUFVACZUWWDX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 600.07 | Molecular Weight (Monoisotopic): 599.1405 | AlogP: 4.59 | #Rotatable Bonds: 7 |
Polar Surface Area: 117.00 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.53 | CX Basic pKa: 4.41 | CX LogP: 4.31 | CX LogD: 2.50 |
Aromatic Rings: 4 | Heavy Atoms: 41 | QED Weighted: 0.32 | Np Likeness Score: -1.54 |
1. Suaifan GARY, Mohammed AAM.. (2019) Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?, 27 (14): [PMID:31182257] [10.1016/j.bmc.2019.05.038] |
Source(1):